Novartis acquires EBEWE's generic injectables business for $1.2 billion
20 May 2009
Simon Varcoe
Novartis is to acquire EBEWE Pharma's generic injectables business for €925 million ($1.2 billion) in cash to strengthen its generics business
Sandoz.
The private Austrian company will retain its smaller injectable neurological products business but will divest products such as paclitaxel, epirubicin,...
Please Login to read the full article.
20 May 2009
Simon Varcoe
The private Austrian company will retain its smaller injectable neurological products business but will divest products such as paclitaxel, epirubicin,...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
